Influenza vaccine effectiveness against detected infection in the community, France, October 2024 to February 2025.

• Tác giả: Claire Nour Abou Chakra, Antonin Bal, François Blanquart, Guillaume Deleglise, Thomas Duret, Vincent Enouf, Stephanie Haim-Boukobza, Alexandra Jacques, Laurence Josset, Bruno Lina, Marta C Nunes, Marie Anne Rameix-Welti, Vincent Vieillefond, Benoit Visseaux, Valentin Wehrle
• Ngôn ngữ: eng
• Ký hiệu phân loại: 235.2 Saints
• Thông tin xuất bản: Sweden : Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin , 2025
• Bộ sưu tập: NCBI
• ID: 238512

Tóm tắt

 Influenza circulates at high levels in Europe since November 2024. Using a test-negative study based on data from French community laboratories between October 2024 and February 2025, we estimated vaccine effectiveness (VE) against PCR-detected influenza infection (44,420/15,052
  positive/negative individuals). For all age groups, the overall VE was 42% (95% CI: 37-46%), with 26% (95% CI: 18-34%) against influenza A and 75% (95% CI: 66-82%) against influenza B. Among individuals ≥ 65-year-olds VE was 22% (95% CI: 13-30%) and among 0-64-year-olds, 60% (95% CI: 56-65%).